SG Cowen Lifts Merck Rating to Strong Buy
SG Cowen upgraded Merck & Co. (MRK ) to strong buy. After the close of trading Jan. 23, the drug maker posted $0.75 vs. $0.66 4Q EPS.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.